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Abstract
Background: The EQ-5D-Y, an outcome measure of Health Related Quality of Life (HRQoL) in children, was
developed by an international task team in 2010. The multinational feasibility, reliability and validity study which
followed was undertaken with mainly healthy children. The aim of this study was to investigate the psychometric
properties of the EQ-5D-Y when used to assess the HRQoL of children with different health states.
Method: A sample of 224 children between eight and twelve years were grouped according to their health state.
The groups included 52 acutely ill children, 67 children with either a chronic health condition or disability and 105
mostly healthy, mainstream school children as a comparator. They were assessed at baseline, at three months and
at six months. An analysis of the psychometric properties was performed to assess the reliability, validity and
responsiveness of the EQ-5D-Y in the different groups of children. Cohen’s kappa, the intraclass correlation
coefficient, Pearson Chi-square, Kruskal-Wallis ANOVA and effect size of Wilcoxon Signed-rank test were used to
determine the reliability, validity and responsiveness of the instrument.
Results: The EQ-5D-Y dimensions were found to be reliable on test-retest (kappa varying from 0.365 to 0.653),
except for the Usual Activities dimension (kappa 0.199). The Visual Analogue Scale (VAS) was also reliable
(ICC = 0.77). Post-hoc analysis indicated that dimensions were able to discriminate between acutely ill and
healthy children (all differences p < 0.001). The acutely ill children had the lowest ranked VAS (median 50,
range 0–100), indicating worst HRQoL and was the only group significantly different from the other three
groups (p < 0.001 in all cases). Convergent validity between all similar EQ-5D-Y and PedsQL, WeeFIM and
Faces Pain Scale dimensions was only evident in the acutely ill children. As expected the largest treatment
effect was also observed in these children (Wilcoxon Signed-rank test for VAS was 0.43). Six of the nine
therapists who took part in the study, found the measure quick and easy to apply, used the information in
the management of the child and would continue to use it in future.
Conclusions: The EQ-5D-Y could be used with confidence as an outcome measure for acutely-ill children,
but demonstrated poorer psychometric properties in children with no health condition or chronic
conditions. It appears to be feasible and useful to include the EQ-5D-Y in routine assessments of children.
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Background
Self-reported HRQoL in children has become increas-
ingly recognised as an important supplementary meas-
ure in assisting health professionals to assess the impact
disease and intervention strategies have on the child’ life.
This should be assessed from the child’s own perspective
with self-reports [1–4]. The use of appropriate age
related HRQoL measures when planning an interven-
tion, ensures that the child’s priorities (which may be
different from that of the health care professional [5])
are met. Studies comparing the child’s self-report with
an adult proxy report, have found that there is often
poor agreement between the two, lending weight to the
importance of HRQoL being self-reported by the child
to capture HRQoL from the child’s perspective [6–9].
These studies found that children do not prioritise
disease-related symptoms and lack of physical ability, as
negatively affecting their HRQoL, whereas the adult
proxy does. Other studies have found that children
prioritise the emotional impact a health condition has
on their HRQoL, whereas adult proxies tend to under-
report on this dimension [10–12]. Tracking changes in a
child’s HRQoL over time enables clinicians to adapt their
management appropriately as the maturing child’s health
condition and needs change [13, 14].
The EQ-5D-Y was developed by an international task
team in 2010 [15] to assess HRQoL in children. As this
version was intended to be comparable with the adult
version EQ-5D, the wording and layout of the EQ-5D
was modified to ensure relevance and clarity for the
cognitive developmental stage of children as young as
eight years. The measure requires children to self-report
on five dimensions of health, namely; Mobility (walking
about), Looking After Myself (LAM), Usual Activities
(UA), Pain or Discomfort (P/D) and being Worried, Sad
or Unhappy (WSU). The child can choose between three
levels of severity (1) no, (2) some or (3) a lot of
problems, which result in a health profile. Additionally,
a Visual Analogue Scale (VAS) allows the child to
subjectively rate their overall HRQoL on a graduated
scale, with 0 indicating worst health state imaginable
and 100 indicating best health.
The EQ-5D-Y has been shown to be reliable and valid
in healthy school children in the general population in
countries such as Sweden [16], South African [17] and
Spain [18] as well as in a multinational study [1],
although different comparators were used in the studies
e.g. paper, web based or adult proxy versions. A study in
the United Kingdom indicated that the EQ-5D-Y was
less reliable than the Child Health Utility 9D in younger
children aged six to seven years and the content validity
was less suitable in addressing issues important to
children, but this may have been due to the age of the
children [19].
There was no standardisation on the time interval
between test and re-test when assessing reliability as it
varied from seven to ten days in the multinational study
[1] to morning/afternoon in the United Kingdom study
[19]. The length of time between administrations could
influence the reliability, but it is recommended to re-test
before a change in HRQoL can occur [20].
The high ceiling effect in the dimensions noted in the
studies on healthy children encouraged further testing in
clinical contexts. There is, however, limited evidence of
the use of the EQ-5D-Y in different disease groups.
Some studies used a cross sectional study design to
assess construct validity of the measure in children with
one specific health condition and reported that the EQ-
5D-Y was valid for children with Cystic Fibrosis [21],
asthma [22] and diabetes mellitus [23]. Similar results
were reported in an Italian study, which found good reli-
ability and acceptable discriminant validity in children
with and without Acute Lymphoblastic Leukaemia [26],
and a Swedish study in children and adolescents with
and without a variety of functional disabilities [16]. In
contrast, other research, which compared the severity in
one specific health condition or across different health
conditions, found the EQ-5D-Y to have limited discrim-
inant validity in children with varying levels of chronic
health conditions [24] and with a range of orthopaedic
conditions [25]. The VAS and the dimensions have been
reported to discriminate in different participation groups.
Discriminant validity on the VAS and not in dimensions
scores was evident in a study with children of different
levels of physical activity [27]. This is in contrast to a
study with healthy children and children with long stand-
ing chronic disabilities, which reported discriminant valid-
ity on dimensions, with disabled children recognising
their limitations on a dimensional level, but not reporting
a lower VAS than their able bodied peers [8]. There are
limited longitudinal studies using the EQ-5D-Y to assess
HRQoL over a period of time but there is evidence that it
is a responsive measure. Changes in the health needs of
children with a variety of mental health problems were
detected over three years [28]; as were changes in HRQol
in children with and without Celiac Disease over one year
[29]. The EQ-5D-Y was found to be as responsiveness as
the KINDLE-R, but less responsive than the KIDSCREEN
10 in capturing changes in a group of children with a
range of health conditions including obesity, diabetes and
respiratory impairments over 20 months [30].
The feasibility and use of the EQ-5D-Y as part of
routine patient data has not been fully explored. Routine
use of the measure could improve health care, by
guiding clinicians planning of interventions, ensuring
that aspects important to the individual child are
addressed. Clinicians might be unaware of the psycho-
logical effects the health condition has on the child and
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this is one way to improve responsiveness to this aspect
of health [31–33]. Similarly shared decision making,
with the use of the EQ-5D-Y could promote communi-
cation between the child and clinician and result in
better adherence to an intervention regime. The effect-
iveness of the intervention could also be monitored
through the use of the HRQoL measure.
The aim of this study was therefore to investigate the
performance of the EQ-5D-Y in children with different
health states.
The aims of this study were therefore to assess reliabil-
ity, validity and responsiveness of EQ-5D-Y in children
with arrange of health states, as well as feasibility for
routine use in a South African setting.
Methods
Study design and setting
An observational, analytical cohort study with repeated
measures was conducted. Four different research set-
tings, each with children in different health states, differ-
ent levels of severity and type of management, were
used. All settings catered for children from a similar
socio-economic background (low to middle income).
A mainstream school with typically developing, mostly
healthy children living in the surrounding areas was
chosen as a comparator (MS group). Two facilities for
chronically ill children were chosen, as the level of
physical disability and management of the conditions
was different at each facility. A Special School catering
for children diagnosed with a congenital, physical dis-
ability limiting mobility, such as spina bifida, muscle
diseases or cerebral palsy and relying on either a wheel-
chair or assistive device for mobility, was used. The
management of their health condition was aimed at
maintaining their limited functional ability through
nursing and rehabilitative services, which were pro-
vided at the school (SS group). The second chronic care
facility, cared for children with an acquired chronic
condition, such as diabetes mellitus, human immuno-
deficiency virus (HIV), neurological disorders and
heart, renal and respiratory impairments. The children
were all independently ambulant, but were admitted to
the facility as their families could no longer provide the
level of nursing care needed. The improved care they
received was aimed at improving their health (CI
group). The fourth setting was an acute care paediatric
hospital managing acutely ill children in intensive care
or in medical, surgical, trauma or oncology wards. Most
of these children were healthy before being admitted to
hospital for acute appendicitis, septic arthritis, leukae-
mia or a bone fracture to name a few conditions. They
were usually hospitalised for no longer than seven days,
as they were discharged once the acute condition had
improved (AI group).
Participants
There were two main groups of participants, children with
varying levels of health and their treating therapists.
The sample size was recalculated based on an antici-
pated moderate effect size between groups, as one of the
aims was to determine whether the EQ-5D-Y could
detect a change in health over time.
A one-way ANOVA using G*Power 3.1.9.2 calculator
(http://www.ats.ucla.edu/stat/gpower) with an effect size of
.3 (moderate difference between groups), an alpha error
probability of .05 and power of .8, was used. The total sam-
ple required was 190, which was exceeded in recruitment.
All children at each facility between the ages of eight and
12 years, were identified and recruited during an onsite
visit. This age range was chosen in order to assess the out-
come measures’ performance in children specifically, as it
was felt that adolescents (13–18 years) would have less
problems in completing the questionnaires. Only children
who returned legible, signed consent and assent forms were
included in the study. Children who were in the terminal
stages of illness or were critically ill, with unstable and/or
abnormally high or low vital statistics were excluded as it
was possible that they and their parents might find partici-
pating in the research study too distressing. Any child who
was unable or unwilling to respond was excluded.
There were 105 mostly healthy children from a main-
stream school recruited. Five of these children were
diagnosed with relatively minor health issues such as
asthma, eczema and headaches. They were not expected to
have HRQoL problems and their health state was expected
to remain stable throughout the study period. The 119 chil-
dren with a health condition were divided into three groups
as each group demonstrated a different level of disease se-
verity and expected outcome. The SS group of 35 children
with a stable, chronic disability all experienced problems
with mobility which was not expected to change over time.
The 32 children in the CI group with an acquired chronic
health condition faced greater emotional challenges adjust-
ing to their acquired health status, compared to the chil-
dren born with a disability (SS group). Their health state
was expected to improve moderately over time as a result
of the improved care they received. The 52 acutely ill, hos-
pitalised children, AI group, experienced problems in all
HRQol dimensions, but this was expected to improve the
most over time, with management of their acute condition.
A convenience sample of nine therapists was interviewed
to determine the feasibility and use of the EQ-5D-Y, as a rou-
tine outcome measure. These were the therapists treating
the children with a health condition at the various facilities.
Measurements
A self-designed contextual information sheet, was used
to record the demographics, general health status and
management of the health condition of each child.
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EQ-5D-Y
The EQ-5D-Y self-report was the primary outcome meas-
ure. The five dimensions, each with one item, do not share
the same underlying construct and the intervals between
the three levels of problems, are not necessarily equal, so
the dimensions were analysed individually. Until recently,
there was no single index score for the EQ-5D-Y summaris-
ing the level of problems reported on each dimension.
Craig et al. [34] developed a summary EQ-5D-Y on a
QALY (Quality Adjusted Life Years) scale which was used
to determine a Composite Score, for comparison with other
HRQol measures which do provide for a total dimension
score. The QALY is a single index obtained by combining
the length of time spent in a particular health state and the
HRQoL weighting or utility score given to that health state.
The QALY values produced by Craig et al. were based on
adult preferences for child health states. Adults were asked
to choose between losses in HRQoL and losses in life span,
in children with a health condition. Paired comparisons of
different health states were used to identify the point at
which participants were indifferent between the choices. At
this point, weights or the value attributed to the loss in
HRQoL, assuming it lasts for one year, informed the QALY
value. However, this has not yet been endorsed by the
EuroQoL Research Foundation [http://www.euroqol.org/].
In addition the VAS allows for a subjective overall
rating of health status on a graduated scale. The
higher the reported VAS, the better the HRQoL [1].
The paediatric quality of life inventory (PedsQL4.0)
The generic PedsQL consists of self-reporting on 23 items,
in four dimensions; About My Health and Activities
(Physical Functioning e.g. “It is hard for me walk more than
one block”) – a total of eight items, About My Feelings
(Emotional Functioning e.g. “I feel afraid or scared”) – five
items, How I Get Along With Others (Social Functioning
e.g. “Other kids tease me”) – five items and About School
(School Functioning e.g. “I miss school because of not feel-
ing well) – five items. The Likert type scoring ranges from
0 to 4 with 0 being “never a problem”, and 4 “almost always
a problem”. Each item is scored and the scores were added
together to produce a dimension sub-score. Therefore the
higher the PedsQL score, the greater the problem in that
dimension and the lower the HRQoL [35].
Faces Pain Scale (FPS)
The FPS, with a series of facial expressions depicting pain
intensity, was also completed by the children. A horizontal
line of six faces, showing progressively worsening pain ex-
pressions, are used to self-rate pain. The first face shows “no
pain”= 0. The next four faces show increasing pain, rated 2,
4, 6, 8 respectively; and the last face shows “very much pain”
= 10. The child marks the face indicating his/her pain level.
A rating of 10 would indicate severe pain [36].
WeeFIM
The observational/interview WeeFIM instrument was
completed by the researcher and not self-reported on as all
the other outcome measures. The WeeFIM gives an indica-
tion of the child’s functional independence, in three dimen-
sions, namely self-care (e.g. eating, grooming etc.) with a
total of eight items, mobility (e.g. transfers from bed to
chair or wheelchair) with five items, communication (e.g.
comprehension) with two items and cognition (e.g. mem-
ory) with three items. The 18 items are each rated on an or-
dinal scale from 1 to 7, ranging from complete dependence
(rated as “1”) to complete independence (rated as “7”). The
scores are summed and therefore the higher the dimension
sub-score, the more independently the person is able to
perform functions in that dimension [37]. The WeeFim
was only completed for children with health conditions,
and for the few MS children who indicated a problem
with “Mobility” on the EQ-5D-Y.
Feasibility and utility questionnaire
The clinical therapists involved in the study completed a
questionnaire designed by the researcher. The time taken
to complete the measure was recorded and compared to
the recommended time of five minutes. The therapists
were asked to comment on the use of the EQ-5D-Y as a
supplement to routine patient assessments. Questions in-
cluded whether additional psychological information of
which they were possible unaware, was obtained; whether
there was a relationship between children’s responses and
observed clinical signs; whether they used the measure to
assist in planning of interventions and whether they would
continue to use the measure in the future.
Procedure
Ethical approval from the Human Research Ethics
Committee of the University of Cape Town (HREC REF
354/2013) and permission from the various institutions
at which the study took place were obtained. Letters
were sent home to parents with children at the various
schools. The letters explained the purpose of the study
and included informed consent forms for parents to sign
and assent forms for children. In the acutely ill, hospita-
lised children consent and assent forms were signed
during face to face interviews with children and their
parents at the bedside. The participating therapists also
signed informed consent forms, during face to face
interviews at each facility.
A pilot study, using the test-retest method on consecu-
tive days, was conducted on a sub-sample of 38 children
from the four different health groups to establish reliabil-
ity of the EQ-5D-Y, in this population group.
Subsequently demographic information was collected
on all 224 children. All outcome measures were admin-
istered on the same day, to small groups of eight
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children at a time, in a quiet room. In the hospitalised
children this was performed individually at the bedside.
Although all the children could understand English,
some children chose to complete the outcome measures
in their home language, Afrikaans. No child chose the
isiXhosa versions, even though they were available.
Afrikaans and isiXhosa are two of the 11 official lan-
guages of South Africa. The EQ-5D-Y was completed
first by each child, followed by the PedsQL and FPS,
with a short break between measures. The researcher
then completed the WeeFIM for all SS, CI and AI
children, but only for the MS children who indicated a
problem with “Mobility” on the EQ-5D-Y. This was done
to assess whether or not they actually did have a fu-
nctional problem. The MS children were healthy chil-
dren, with no functional problems and were therefore
expected to show a ceiling effect in WeeFIM scores.
Baseline measures for the AI children were taken two
days post hospital admission, allowing the child time to set-
tle in, and repeated just prior to discharge, approximately
five days later. A third assessment was taken at either two
weeks or one month later, if the child was still hospitalised.
Only the longer stay, AI children were therefore assessed
three times. The other three groups were assessed at
baseline, three months and six months after baseline.
All repeat assessments followed the same procedure.
At the end of the study, the therapists completed the
feasibility and utility questionnaire.
Statistical analysis
Descriptive statistics were used to describe the sample. A
One Way ANOVA was used to determine whether there
were significant differences in mean ages of the children.
A Chi-squared test (Chi2) was used to determine whether
gender was significantly associated with health group.
Cohen’s unweighted, kappa coefficient of agreement
between the children’s responses for EQ-5D-Y dimen-
sions, tested 24 h apart used to assess reliability. Kappa
values were interpreted according to Landis and Koch’s
guidelines [38] with kappa <0.2 indicating poor agree-
ment, 0.21–0.40 indicating fair agreement, 0.41–0.60
moderate agreement, 0.61–0.80 substantial agreement,
and kappa >0.81 indicating almost perfect agreement.
The VAS scores were not normally distributed (KS < 0.01
throughout) and non-parametric analysis was used to
compare the groups. A two-way mixed effects model, type
A Intraclass Correlation Coefficient (ICC) for absolute
agreement (95% Confidence Interval) for VAS was used to
assess reliability of VAS scores. An ICC >0.7 was generally
considered as acceptable for test–retest reliability [1].
Discriminant validity of the EQ-5D-Ywas examined by
comparing the HRQoL profiles of the different groups of
children, known to be different (healthy, chronically dis-
abled, acquired chronic conditions and acutely ill children).
The level of problem reported in each EQ-5D-Y dimension,
per group, was compared using the Fisher’s exact test, ra-
ther than Chi2 test as some cells were sparsely populated.
Post hoc analysis, using Kruskal-Wallis H test, indicated
which groups were significantly different from each other.
Concurrent validity was assessed by comparing the
EQ-5D-Y dimension profiles summarised using the
Composite Score, with the self-perceived global percep-
tion of health, VAS. The Composite Score was calculated
using the QALY weightings suggested by Craig et al.
[34]. Spearman’s Rho was used to determine correlations
between Composite Score and VAS. In line with the
guidelines provided by Cohen [39], correlations from 0.1
to 0.29 were considered low, 0.3 to 0.49 moderate and
correlations of 0.5 or above as high.
Convergent validity of the EQ-5D-Y dimensions was
examined by correlating the dimension scores for the dif-
ferent groups with scores on similar dimensions of the
PedsQL, WeeFIM and the FPS. Kruskal-Wallis H value
was determined. When there were five or fewer scores for
a particular problem level (1, 2 or 3) on the independent
EQ-5D-Y variable, this level was excluded and the Mann–
Whitney U Test was used to compare the remaining two
levels. Spearman’s Rho was used to determine correla-
tions between EQ-5D-Y Composite Score and VAS.
Responsiveness of the EQ-5D-Y to depict a change in
health in repeat measures taken three months post base-
line, was described by examining the effect size (r) of
Wilcoxon Signed-rank test (Z). It was calculated by
r ¼ zﬃﬃﬃ
N
p 1 where N is the total number of responses at base-
line and at three months, not the number of participants.
Effect size was interpreted as 0.1 being considered small,
0.3 medium and 0.5 large.1
Feasibility was assessed by the time taken to complete
the EQ-5D-Y. The usefulness of the measure was assessed
by analysing the frequency of positive responses in the
questionnaire completed by the participating therapists.
Results
Figure 1 there were no missing responses on the EQ-5D-Y
or PedsQL, as the researcher asked the child whether the
missing response was due to the child not wanting to pro-
vide a score for that item or if the child had forgotten to
provide a score for the item. The few children with missing
responses did so inadvertently and were willing to provide
the missing score, without coercion.
The mean age was 10.5 years (SD = 1.45) and there
was no significant difference in age between the four
groups of children F = (3, 220) = 1.03, p = .379. Gender
distribution was also not significantly associated with
any group (Chi2 = 1.43; p = .698).
Table 1 indicates the health status of the different
groups. As was expected, the majority of the MS
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children did not have a health condition, although
eight reported minor ailments (asthma, eczema and
headaches). All the SS children were diagnosed with a
disability which limited their functional independence
e.g. cerebral palsy (n = 12), spina bifida (n = 10). The
CI children with no mobility limitations were admit-
ted for management of a chronic health condition e.g.
HIV (Human immunodeficiency virus) (n = 8), dia-
betes mellitus (n = 8). The most common conditions
seen in the AI group were appendicitis (n = 7), joint
injuries (n = 7) and neoplasms (n = 6).
Reliability
Test-retest reliability of EQ-5D-Y dimension scores
This was performed in a pilot study, on a small sample
of convenience of children from each of the four
health groups. Nine MS children, five SS and nine CI
children and 15 AI children, completed question-
naires, 24 h apart. Table 2 shows Mobility, LAM and
WSU dimensions fell within the moderate level of
agreement, while P/D indicated fair agreement, across
all four groups. Only UA dimension fell within the
slightly agreed category (kappa = 0.199, p < .127).
Fig. 1 Flow diagram indicating the number of participants at each stage of the study
Table 1 Health status of participants in each group
Group Chronic Health status Acute Health status No health condition Totals (n)
MS 8 (7.6%) 0 97 (92.4%) 105
SS 35 (100%) 0 0 35
CI 32 (100%) 0 0 32
AI a3 (5.8%) 49 (94.2%) 0 52
All Groups 78 (34.8%) 49 (21.9%) 97 (43.3%) 224
MS Healthy mainstream school children, SS Children with a chronic physical disability, CI Chronically ill children, AI Acutely ill children
n = 224
aThese three children were treated for an acute health problem, unrelated to their chronic condition
Scott et al. Health and Quality of Life Outcomes  (2017) 15:12 Page 6 of 14
Test-retest reliability of VAS scores
The intraclass correlation coefficient (ICC) for all groups
for VAS was found to be .765 (95% Confidence intervals
(CIs) = .594-.870), which indicated strong agreement
between the two sets of VAS scores.
Discriminant validity
Discriminant validity was examined by comparing the
responses on the different dimensions across the groups
of children with different health states.
EQ-5D-Y dimensions
Mobility dimension Figure 2 discriminant validity was
evident between the AI group with significantly more
reported problems with Mobility and the other three
groups. The SS group reported significantly more Mo-
bility problems than the MS group, demonstrating
discriminant validity between these two groups in this
dimension.
Looking After Myself (LAM) Dimension Figure 3 the
SS and AI groups reported significantly more problems
with Looking After Myself, than the MS group with few
problems, but the SS and AI groups were not signifi-
cantly different from each other.
Usual Activities (UA) dimension Figure 4 the AI group
reported significantly more problems in the Usual Activ-
ities dimension compared to the other groups.
Pain/Discomfort (P/D) dimension Figure 5 the only
groups significantly different from each other were the
AI group with significantly more pain than the MS
group.
Worried, Sad or Unhappy (WSU) dimension Figure 6
again the only groups significantly different from each
other were the AI with more Worried, Sad or Unhappy
dimension problems than the MS group.
Overall the AI children reported the most problems
on level 3 for all dimensions. The MS children reported
the least problems in all dimensions apart from WSU
dimension, in which 4.8% indicated problems on
level 3 (lots of problems), compared to only 3.1% of
CI children.
Table 2 Agreement between first and second EQ-5D-Y
dimension scores
Kappa Strength of agreement p
Mobility .546 moderate p < .001
LAM* .653 good p < .001
UA* .199 poor p < .127
P/D* .365 fair p < .08
WSU* .551 moderate p < .001
n = 38
*LAM (Looking After Myself), *UA (Usual Activities), *P/D (Pain/Discomfort),
*WSU (Worried, Sad or Unhappy)
Significant p values are bolded
Fig. 2 Percentage of Mobility dimension problems for each group.
n = 224 p < .001 i.e., p = 1.3E-17. Fisher’s exact test, p < .001.
Kruskal-Wallis test: H (3, N = 224) =71.058 p < .001
Fig. 3 Percentage of LAM dimension problems for each group.
n = 224. Fisher’s exact test, p < .001. Kruskal-Wallis test:
H (3, N = 224) =45.349 p < .001
Fig. 4 Percentage of UA dimension for each group. n = 224.
Fisher’s exact test, p < .001. Kruskal-Wallis test: H (3, N = 224)
=85.311 p < .001
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EQ-5D-Y composite scores
The Composite Score, summarising dimension profiles
and calculated using the QALY values suggested by
Craig et al. [34], was compared across groups. Note that
the higher scores indicate more problems on the dimen-
sions and worse HRQoL.
Figure 7 indicated that the MS children with a median
Composite Score of .15, experienced significantly fewer
problems on dimensions compared to the AI children
with a Composite Score of 2.8 with significantly more
problems and worse HRQoL. There was no discriminant
validity between the two groups of children with chronic
health conditions, the SS and the CC groups (Composite
Scores of 1.4 and .75 respectively).
EQ-5D-Y VAS scores
The AI group VAS (median of 50) was ranked signifi-
cantly lower than and the other three groups (all with a
median of 100) and not ranked significantly different
from each other (Fig. 8).
Concurrent validity
The dimension profiles as summarised by the Composite
Score were compared with the self-perceived global
perception of health, VAS, to assess concurrent validity.
One outlier was removed from the CI for the scatter-
plot only. Removing the outlier from the scatterplot did
not change the results, as can be seen in Spearman’s
correlation below. The outlier was included in all
other analyses.
There was no correlation between the VAS and Com-
posite Score in any group apart from the AI children
(Fig. 9 and Table 3).
Convergent validity
Convergent validity of the EQ-5D-Y was examined by
correlating the dimension scores for the different groups
with their scores on similar dimensions of the PedsQL,
WeeFIM and the FPS. Correlations between EQ-5D-Y
Composite Score, VAS, PedsQL and WeeFIM total score
were also examined (Table 4). It should be noted that
the MS group were excluded from the analyses using
the WeeFIM, as these children did not demonstrate a
functional limitation.
It would seem that all similar EQ-5D-Y and PedsQL
dimensions were correlated in the AI group only. All
similar EQ-5D-Y and WeeFIM dimensions were
correlated for SS, CI and AI children. The EQ-5D-Y
Pain/Discomfort dimension the Faces Pain Scale were
correlated in the AI group only. There were signifi-
cant correlations between total scores of all outcome
measures for the AI group, only.
Responsiveness of EQ-5D-Y over time
The ability of the EQ-5D-Y to depict a change in HRQoL
between baseline and three months was examined to
determine the responsiveness of the measure. Res-
ponsiveness was described by examining the effect size
effect size (r) of Wilcoxon Signed-rank test (Z), calcu-
lated by r ¼ zﬃﬃﬃ
N
p where N is the total number of
responses at baseline and at three months (Table 5).
The Composite Scores and VAS scores over time were
examined for responsiveness.
The Composite Scores and VAS both indicated medium
effective size and responsiveness for both CI and AI
groups, the two groups at which change was expected,
due to management of the children’s health conditions.
Feasibility and usefulness of EQ-5D-Y outcome measure
All the children completed the EQ-5D-Y within the
recommended time of five minutes.
Nine clinical therapists assisted in administering the
EQ-5D-Y to some children. Six of the therapists found the
measure very easy to use. The reported reason for three
Fig. 5 Percentage of P/D dimension problems for each group.
n = 224. Fisher’s exact test, p < .001. Kruskal-Wallis test:
H (3, N = 224) =21.030 p < .001
Fig. 6 Percentage of WSU dimension problems for each group.
n = 224. Fisher’s exact test, p < .001. Kruskal-Wallis test:
H (3, N = 224) =25.895 p < .001
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therapists finding it only moderately easy to use was time
restraints. Two therapists reported that eight and nine
year- old AI children had some difficulties understanding
the UA dimension. A relationship between responses and
objective clinical signs was mostly noticed in the EQ-5D-Y
Mobility dimension and ability to walk followed by P/D
and WSU. All therapists found the measure useful in
planning the management of the child, especially the
information on P/D and WSU. Six of the therapist agreed
that they would continue to use the instrument to assist
the planning and monitoring of an intervention.
Discussion
As the measure has been found to be reliable in other
studies on children with and without health conditions
[1, 16, 18, 26] including in South Africa [17], a pilot
study with 38 children was used to confirm reliability in
the four groups. Fair to good test-retest agreement in
EQ-5D-Y dimensions except for the UA dimension, was
demonstrated in the small sub group of children chosen
from each of the four facilities. Of concern was the lack
of consistency in the UA dimension. It would seem that
the child might have been relating to a different, specific
Composite score













Fig. 7 Median Composite Score per group. n = 224. Kruskal-Wallis test: H (3, N = 224) =72.86 p < .001
Median VAS scores per group
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Fig. 8 Median VAS per group. n = 224. Kruskal Wallis (H (3, N = 224) =62.81 p < .001)
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usual activity each time, as several examples of usual
activities are included in the questionnaire to explain the
construct (going to school, hobbies, sports, playing,
doing things with family or friends and…). Further quali-
tative research would be required to determine the
childrens understanding of this dimension, backed up by
a reliability study on a larger sample than in this paper.
The agreement between VAS scores was rated as good,
in the small sample. The time interval of 48 h between
test and retest was deemed appropriate as the health
status was likely to change in the AI children, over a
longer period, but was long enough to ensure that the
children would not remember their initial score, as
recommended by Devon et al. [40].
The EQ-5D-Y performed the best in acutely-ill chil-
dren and the measure was able to discriminate between
them and all the other groups of children, whether
assessing dimensions, Composite Scores or the VAS. It
seems that children with an acute health condition were
able to respond most appropriately to the EQ-5D-Y,
reporting accurately on the impact of their health condi-
tion in dimensions and VAS. They reported the most
problems on all dimensions and the Composite score,
summarising dimension scores, correlated with lowered
VAS scores, despite the composite score being based on
adults valuing health losses of a child and the VAS being
the child’s perception of their own health. An Italian
study also found that the EQ-5D-Y could differentiate
between children from the general population and
children diagnosed with Acute Lymphoblastic Leukae-
mia, who reported more problems on four of the five
dimensions (with the exception being Mobility) and
lower VAS [26].
It was expected that the mostly healthy MS children
would report relatively few problems with a high ceiling
effect as was found in other studies with children from
the general population [1, 19, 21, 26, 41]. While over
75% of these children did report no problems on any
dimension and a median VAS of 100, there were some
unexpected results in the Mobility and Pain and Discom-
fort dimensions. Some of these children (14%) reported
problems with Mobility on the EQ-5D-Y, but this was not
reflected when they were assessed by the researcher on
the functional independence outcome measure, the
WeeFIM. This may reflect an interpretation and context-
ual issue with the EQ-5D-Y in these children. It would
seem that they did not always relate problems with
“Mobility (Walking About)” to a health state, but rather to
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Fig. 9 Scatterplot of VAS versus Composite Score
Table 3 Spearman Rank Order Correlations between VAS and
Composite Scores across groups
n Spearman Rho P value
MS 105 -.047 .638
SS 35 .304 .075
CI 32 -.202 .268
AI 52 −0.786 p < .001
Significant p values are bolded
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environmental barriers, such as a lack of safety in the high
crime areas in which they lived. Additionally, unexpect-
edly high numbers of MS children (21%) reported some
problems in the Pain or Discomfort dimension, but this
was not evident when they reported pain levels on the
Faces Pain Scale. It could be that the children were report-
ing on relatively minor and transient pain on the EQ-5D-
Y, as only two of the five children with asthma, eczema or
headaches reported pain on the EQ-5D-Y. There was also
a lack of correlation between the Composite Score,
Table 4 Summary of significant correlations between the different instruments per group
Group Instrument EQ-5D-Y dimensions EQ-5D-Y
VAS
EQ-5D-Y
Composite ScoreMobility LAM UA P/D WSU
MS PedsQL “Feelings” p = .02
−2.318b
PedsQL total p = .007
−2.682b
p = .041 Rho .199
SS PedsQL “Health and Activity” p < .001
16.7a
WeeFIM Mobility p < .001
22.12a
WeeFIM self-care p < .001
14.19a
PedsQL total p = .009
Rho .441
CI WeeFIM Mobility p = .01
9.19a
WeeFIM Self-care p = .013
8.69a




WeeFIM total p = .024
Rho -.398
AI PedsQL “Health and Activity” p < .001
15.81a
PedsQL “I hurt” p < .001
26.78a
PedsQL “Feelings” p = .007
12.14a
WeeFIM Mobility p < .001
21.75a
WeeFIM Self-care p < .001
15.57a
FPS p < .001
29.76a











bMann–Whitney U z value
Significant p values are bolded
Table 5 The effect size of the EQ-5D-Y Composite Score and Vas Score between baseline and 2nd assessment, across groups
MS SS CI AI
















Significant p values are bolded
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summarising dimension scores and VAS in the MS chil-
dren which could be attributed to the Composite Score
being based on adults valuing health losses of a child, but
this did not affect the results found in the acutely ill chil-
dren. It is possible that children who have not experienced
a serious health condition may not be able to differentiate
between health related quality of life and general quality
of life. This could affect the validity of the EQ-5D-Y in
healthy children. These findings suggest that the EQ-5D-Y
should be used with caution in children with transient,
minor health conditions or no health condition and that
the measure may be limited in detecting moderate impair-
ments or discriminating between groups of healthy
children.
It is acknowledged that the sample size of the children
with chronic disabilities and chronic acquired conditions
(35 and 32 respectively) was small, which is a limitation
of the study. From the results it would appear that this
small sample of children were able to recognise and
report their problems appropriately on the five EQ-D-Y
dimensions. However, similar to another South African
study [8], the VAS of these children was equivalent to
the MS children, with a median of 100, which does not
reflect the level of problem reported on dimensions. The
reasons for this disparity need further investigation to
understand how children with chronic conditions con-
ceptualise health on the VAS. It could be that hedonic
adaptation [42] takes place whereby the children with
chronic conditions recalibrate their perception of good
health [43]. This was also reported on in a German
study assessing the validity of the EQ-5D-Y in children
with cystic fibrosis. These authors suggested that the
children learned to cope with the limitations imposed on
their HRQoL by the disease and did not perceive this as
a negative effect [21]. Alternative explanations could be
that other constructs underpin the children’s views of
their health, such as their satisfaction with participation
in their school environment and strong social supports
within this context, despite problems on a dimensional
level. Another limitation in using the EQ-5D-Y in
children with a chronic condition is that discriminant
validity was not evident between the two groups with
chronic conditions, despite significant differences in
their Mobility, however the sample size was small. A
Swedish study assessing the use of the EQ-5D-Y in
children with chronic functional disabilities and healthy
children, found that the children with chronic disabilities
also reported significantly more problems on dimen-
sions and lower VAS, but discriminate validity be-
tween chronic conditions was not analysed [16].
Concurrent validity between the EQ-5D-Y Composite
Score and VAS and the other outcome measures
(PedsQL, WeeFIM and FPS) total scores, was demon-
strated in the AI children only. This further supports the
validity when using the EQ-5D-Y in acutely ill children.
It should be noted that the EQ-5D-Y Composite Score is
not ideal as it is derived from an adult valuing losses in
a child’s health QALY value and has not yet been for-
mally endorsed by the EuroQoL group. A few paediatric
studies have used the Composite Score, but these studies
have been conducted for economic evaluations and
resource allocation purposes [44–47].
Convergent validity was evident between all similar
EQ-5D-Y and PedsQL dimensions in the AI group only.
This pattern of association was not evident in the other
groups of children and could possibly be attributed to
fewer variations in EQ-5D-Y scores, in these groups of
children compared to AI children. However, for all
groups tested (SS, CI and AI) the convergent validity
against the WeeFIM, which the researcher completed,
was high (rho = −0.60) indicating that the children
were able to reliably describe their functional prob-
lems on the EQ-5D-Y.
The EQ-5D-Y Composite and VAS scores both demon-
strated responsiveness in that they improved significantly
in children who were expected to show improvement, i.e.
the AI and the CI children, with a medium effect. This
implies that the EQ-5D-Y is a useful measure to monitor
change over time and that, even in relatively small num-
bers of children such as the CI group, a change can be
detected. Similarly a moderate effect size for EQ-5D-Y
VAS, was calculated in a study comparing responsiveness
of the EQ-5D-Y, KIDSCREEN-10 and KINDL- R, in a
clinical sample of children with chronic conditions.
However this study only found limited changes in dimen-
sion scores over time [30].
All therapists administrating the EQ-5D-Y found it
easy and quick (five minute) to administer and re-
ported that it provided them with information on the
child’s HRQoL that they were previously unaware of,
particularly on the less obviously observable dimen-
sions of Pain or Discomfort and Worried, Sad or
Unhappy domains.
Limitations and recommendations
The sample size calculation of 190 children in total was
based an anticipated moderate effect size between
groups, however the results could have been biased by
the small numbers in the two chronically ill groups.
Further qualitative research is recommended to clarify
how healthy children interpreted “Mobility (walking
about)”, “Usual Activities” and “Pain or Discomfort”, as
there was limited reliability for the Usual Activity
dimension and the EQ-5D-Y scores for Mobility and
Pain or Discomfort were not associated with other
outcome measures assessing the same construct.
The dimensions yielded intuitively correct results in
the chronically ill children, but more research is
Scott et al. Health and Quality of Life Outcomes  (2017) 15:12 Page 12 of 14
required to understand the adaptations these children
adopt in adapting to their situation and evaluating
their overall HRQoL with a high VAS score similar to
the healthy children.
Conclusions
Despite the limitations in sample size, the problems the
healthy children encountered in completing the EQ-5D-
Y and possible adaptation occurring in chronically ill
children, the study did yield useful information. The
EQ-5D-Y fulfilled the psychometric requirements in the
acutely ill children did not perform as well in the other
groups. As it is short, responsive to change and accept-
able to the users, it is recommended that it could be
used as a routine measure within an acute care setting,
as well as an outcome measure to monitor the impact of
interventions. It should be used with caution in healthy





AI: Acutely ill group of children; CI: Chronically ill group of children with
chronic health conditions; EQ-5D: European Quality of Life (EuroQol) five
dimension - adult version; EuroQoL Group: The EuroQol group association
comprises a network of international, multilingual, multidisciplinary
researchers; FPS: Faces pain scale; HIV: Human immunodeficiency virus;
HRQoL: Health related quality of life; ICC: Intraclass correlation coefficient;
LAM: Looking after myself; MS: Mainstream school children;
PedsQL: Paediatric quality of life inventory version 4.0 generic core scales;
QALY: Quality adjusted life years; SD: Standard deviation; SS: Special school
children with chronic physical disabilities; VAS: Visual analogue scale;
WeeFIM: Paediatric functional independence measure
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